Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Prevalence of Obstructive sleep apnea
18 evidence topics · 15 sources
Company estimate: 80 million US adults aged 30 to 69 and one billion people worldwide (Clarivate study commissioned by Apnimed)
Company estimate: newly diagnosed, diagnosed and active in care, and diagnosed but untreated US adults (claims databases and a survey)
Company estimate: new diagnosis rate and initial target population, September 2026 corporate presentation
Company estimate: share of middle-aged and older adults with OSA who are not obese (third-party study supported by Apnimed)
US prevalence in 2024, AHI4 of 5 or more, adults aged 20 years and older (systematic review and obesity-adjusted projection by Clarivate and Apnimed authors)
“A literature-based systematic review was conducted to identify studies of OSA prevalence in adults using the AHI4 criteria (all apneas plus hypopneas associated with ≥4% oxygen desaturation).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“OSA was defined as having an AHI4 ≥ 5 events/hr.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 83.7 million adults (aged 20 years and older) were estimated to be living with OSA in the US in 2024, of whom 49,459,041 (59%) were males and 34,257,378 (41%) females.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“This translates to 32.4% overall prevalence in the US among adults aged 20 years and older, with 39.1% among males and 26.0% in females, adjusting for obesity.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The distribution of OSA severity was estimated to be 52% mild, 30% moderate, and 18% severe.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“I.S. and A.V.D. are employees of Clarivate Analytics. K.S.Y., J.C., and J.Y. are employees of Apnimed, Inc.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Self-reported diagnosed but untreated sleep apnea, US adults aged 18 to 90 (National Sleep Foundation survey with support from Inspire Medical Systems)
US prevalence in 2007 to 2010, AHI of 5 or more and 15 or more with 4% desaturation hypopnea rule, adults aged 30 to 70 (Wisconsin Sleep Cohort extrapolated to NHANES body mass index distributions)
“A discernible reduction in the sum of thoracic plus abdomen respiratory inductance plethysmography amplitude associated with a 4% or more reduction in oxyhemoglobin saturation defined a hypopnea event.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The current prevalence estimates of moderate to severe sleep-disordered breathing (apnea-hypopnea index, measured as events/hour, ≥15) are 10% (95% confidence interval (CI): 7, 12) among 30–49-year-old men; 17% (95% CI: 15, 21) among 50–70-year-old men; 3% (95% CI: 2, 4) among 30–49-year-old women; and 9% (95% CI: 7, 11) among 50–70 year-old women.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“These estimated prevalence rates represent substantial increases over the last 2 decades (relative increases of between 14% and 55% depending on the subgroup).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Summing over age × sex × BMI strata, we estimated the overall prevalence of mild to severe SDB (AHI ≥5) to be 26% (95% confidence interval: 24, 28) among person 30–70 years of age for the recent time period (2007–2010).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Similarly, the estimated overall prevalence of moderate to worse SDB (AHI ≥15) was 10% (95% confidence interval: 8, 11).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We also estimate that 14% of men and 5% of women have an AHI ≥5 plus symptoms of daytime sleepiness.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Global prevalence, AHI of 5 or more and 15 or more with AASM 2012 criteria, adults aged 30 to 69 (ResMed-funded)
“A conversion algorithm was created for studies that did not use the American Academy of Sleep Medicine (AASM) 2012 scoring criteria to identify obstructive sleep apnoea, allowing determination of an equivalent apnoea-hypopnoea index (AHI) for publications that used different criteria.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Using AASM 2012 diagnostic criteria and AHI threshold values of five or more events per h and 15 or more events per h, we estimated that 936 million (95% CI 903–970) adults aged 30–69 years (men and women) have mild to severe obstructive sleep apnoea and 425 million (399–450) adults aged 30–69 years have moderate to severe obstructive sleep apnoea globally.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The number of affected individuals was highest in China, followed by the USA, Brazil, and India.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“AVB, KV, and CMN are employees of ResMed.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Funding ResMed.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
US prevalence, AHI of 5 or more and 15 or more with AASM 2012 criteria, adults aged 30 to 69 (country table of the global estimate)
| Measure | United States |
|---|---|
| Population aged 30–69 years | “163 246 772”View highlighted excerpt for this quote |
| AHI ≥5 events per h, n (%) | “54 131 654 (33·2%)”View highlighted excerpt for this quote |
| AHI ≥15 events per h, n (%) | “23 678 109 (14·5%)”View highlighted excerpt for this quote |
US prevalence projected from 2020 to 2050, AHI of 5 or more, adults aged 30 to 69, hypopnea scoring rule not stated (ResMed-funded simulation model)
“This study was funded by Resmed.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Obstructive sleep apnoea diagnosis was based age, sex, BMI, and AHI, a metric reflecting the number of apnoea and hypopnoea events per hour of sleep,22 with individuals considered to have obstructive sleep apnoea if their AHI was 5/h or higher.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“By 2050, the prevalence of obstructive sleep apnoea (apnoea–hypopnoea index ≥5/h) is expected to show a relative increase of 34·7%, from 34·3% (95% uncertainty interval [UI] 34·0–34·4) to 46·2% (46·0–46·4), resulting in 76·6 million cases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Males are projected to show a more moderate relative increase of 19·3%, from 45·6% (45·4–46·0) to 54·4% (54·2–54·7), reaching 45·9 million cases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Projections indicate that obstructive sleep apnoea will affect 76·6 million adults aged 30–69 years across the USA in 2050, with a disproportionate growth among females compared with males.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Prevalence of AHI of 15 or more with AASM 2012 hypopnea rule, adults aged 40 to 85 in Lausanne, Switzerland (HypnoLaus)
“We used the 2012 criteria for our analysis (because they are the most recent and currently recommended criteria) and reported the average number of apnoea and hypopnoea events per h of sleep (the apnoea-hypopnoea index).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“1024 (48%) participants were men, with a median age of 57 years (IQR 49–68, range 40–85) and mean body-mass index (BMI) of 25·6 kg/m2 (SD 4·1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The prevalence of moderate-to-severe sleep-disordered breathing (≥15 events per h) was 23·4% (95% CI 20·9–26·0) in women and 49·7% (46·6–52·8) in men.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Prevalence of an apnea-hypopnea score of 5 or more, employed Wisconsin adults aged 30 to 60 (Wisconsin Sleep Cohort, polysomnography)
“A random sample of 602 employed men and women 30 to 60 years old were studied by overnight polysomnography to determine the frequency of episodes of apnea and hypopnea per hour of sleep (the apnea-hypopnea score).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The estimated prevalence of sleep-disordered breathing, defined as an apnea-hypopnea score of 5 or higher, was 9 percent for women and 24 percent for men.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“We estimated that 2 percent of women and 4 percent of men in the middle-aged work force meet the minimal diagnostic criteria for the sleep apnea syndrome (an apnea-hypopnea score of 5 or higher and daytime hypersomnolence).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Range of general-population prevalence across 24 studies, AHI of 5 or more and 15 or more (systematic review)
“Twenty-four studies out of 3807 found by systematically searching PubMed and Embase databases were included in this review.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“At ≥5 events/h apnea-hypopnea index (AHI), the overall population prevalence ranged from 9% to 38% and was higher in men.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“It increased with increasing age and, in some elderly groups, was as high as 90% in men and 78% in women.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“At ≥15 events/h AHI, the prevalence in the general adult population ranged from 6% to 17%, being as high as 49% in the advanced ages.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Prevalence in clinical populations: bariatric surgery candidates and people with stroke or transient ischemic attack
“In some populations, the prevalence of OSA is substantially higher than this estimate, for example, in patients being evaluated for bariatric surgery (estimated range of 70% to 80%)11 or in patients who have had a transient ischemic attack or stroke (estimated range of 60% to 70%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Undiagnosed share of moderate to severe sleep apnea syndrome, employed adults in Wisconsin
Diagnosed and undiagnosed US adults, AHI over 5 (Frost & Sullivan report commissioned by the AASM)
Diagnosed prevalence in US insured adults and children with claims activity, 2013 to 2016 (nationwide claims, Jazz Pharmaceuticals-funded)
“Nationwide medical/prescription claims (Symphony Health) were analyzed to estimate the annual prevalence per 100,000 persons of narcolepsy and other sleep disorders (obstructive sleep apnea, idiopathic hypersomnia, rapid eye movement sleep behavior disorder, periodic limb movement disorder) and the frequency of diagnostic sleep testing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Obstructive sleep apnea prevalence increased 41% over the study period from 2,429 to 3,420 per 100,000.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This study was funded by Jazz Pharmaceuticals.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote